NSAIDS/Nonopiods Flashcards
Arachidonic acid pathway
Cell injury -> phospholipase -> arachidonic acid ->COX breaks down arachidonic acid -> PGs (prostacyclin PGI2, PGE2) and thromboxane
NSAIDS block COX activity and push pathway into lipoxygenase -> leukotrienes (MOA for Asthma)
NSAIDS not good for those w asthma
PG role in pain and inflammation
Mostly COX -2
Cytokines (TNFa, IL-1, IL-8) liberate PG at sites of inflammation
Act on PG receptors to cause pain and inflammation
Work on dorsal horn of spine: increase sensitivity of adenyklate cyclase to stimulation of pain
Enhance neurotransmitter releases and act post synaptically
COX 1 vs COX 2
COX -1 : constitutive and physiologic - around all the time - protective housekeeping
COX -2: inductively during times of inflammation (inflammation and pain)
PG housekeeping
1 GI protective: increase blood flow, mucus production, gastric bicarbonate secretion and decrease gastric acid secretion
- Renal vasodilation (PGE2, PGI2): inhibit sodium and chloride reabsorption, decrease BP, increase blood flow to kidneys
- fever (PGE2)
4 Uterine contraction (PGE2)- use for menstrual pain
Thromboxane activities
Promote platelets aggregation (COX-1)
Vasoconstriction
Vascular proliferation
Prostacyclin is opposites and COX-2
NSAID MOA
Reversible inhibit COX-1 in platelets (COX-1 only isoform in platelets)
Indications:
Inflammation, surgery, arthritis (RA,OA)
Pain in multiple disease states: cancer, muscle, bone, menstrual
KILLS MORE PTS BY SERIOUS ADVERSE EFFECTS THEN ANY OTHER MED
NSAID adverse effects: GI
- GI:
Cox inhibition and local irritation,
Increased age, concurrent GI problems, smoking, alcohol use, steroid use (risk factors)
Can reduce issues with proton pump inhbitors (misoprostol) and high dose histamine-2 blockers
Ketorlac worse for GI
NSAID adverse effects: Renal
Renal patients more dependent on renal blood flow
PGs control renal blood flow: inhibit reabsorption of chloride ions actions of ADH (vasopressin)
ADH normally makes you retain water, PG make you pee
5 mm Hg increase in BP for non selective NSAIDs
NSAIDS can cause salt retention, hyperkalemia, edema
Reduced GFR can precipitate renal failure (ketoraloc)
NSAID adverse effects: drug interactions
ACE inhibitors: block production of vasodilator/natiuretic PG - block anti HT effects
Corticosteroids: increase risk of GI ulceration
Warfarin: increase rIsk of bleed
Warfarin, sulfonylureas, methotrexate: displacement from protein binding
Acetatmetophen
Peripherally blocks pain impulse generation
Inhibition of hypothalamic heat-regulating venter
Selective COX-2 inhibitor
NO EFFECT on platelet function, NO ANTIINFLAM
Fewer adverse effects then other nonopiod analgesics
USES: mild to mod pain (headache), antipyretic, OA pain
Acetatmetophen adverse events
Hepatoxicity
Low dose elimated by glucuronidation, sulfination
High dose: N-hydrocylation -> NAPQI -> mopped up by glutathione (GSH) -> excreted in urine
Overdose: GHS depleted-> NAPQI binds covalently to macromolecules -> apoptosis
Precautions:
Liver disease, alcoholics
Max dosel: 4g/day (less if elderly or alcoholic)
Aspirin
Analgesic, antiinflammatorym antipyretic
Antiplateltte effect: irreversibly binds and acetylates active site on COX (thromboxane)
Cardioprotective
Do not use with NSAIDS
COX-2 inhibitors
Designed to preserve COX-1
Beneficial anti inflammatory, analgesic, antipyretic effects without GI and platelet effects that are mediated through COX-1
Will not reverse cardioprotective properties of aspirin (not COX-2 mediated)
Reduce GI complications but increase CV events vs traditional NSAIDS
COX-2 also found in CNS and kidney
Cause fluid retention and SBP